Preoperative chemotherapy is a better strategy than upfront surgery in cT4 gastric cancer.
Andre Roncon DiasMarina Alessandra PereiraMarcus Fernando Kodama Pertille RamosUlysses Ribeiro JuniorBruno ZilbersteinSergio Carlos NahasPublished in: Journal of surgical oncology (2022)
Multimodal treatment associating CMT with surgery, regardless of whether the approach is pre- or postoperative, is essential to improve the survival of cT4 GC. As tolerance to adjuvant treatment is reduced, preoperative CMT is a better strategy than upfront surgery in these patients.
Keyphrases
- minimally invasive
- coronary artery bypass
- patients undergoing
- end stage renal disease
- computed tomography
- surgical site infection
- chronic kidney disease
- newly diagnosed
- prognostic factors
- squamous cell carcinoma
- peritoneal dialysis
- dual energy
- positron emission tomography
- combination therapy
- acute coronary syndrome
- locally advanced
- chronic pain
- replacement therapy
- patient reported outcomes
- smoking cessation
- gas chromatography